EcoDrugPlus

Melanocortin 1 Receptor

Ensembl ID : ENSLCRG00005000275
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSLCRG00005023069
Gene Symbol: MC4R
3 Cross references
89 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSLCRG00005017735
Gene Symbol: MTNR1AA
3 Cross references
186 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSLCRG00005010326
Gene Symbol: MME
3 Cross references
231 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSLCRG00005015126
Gene Symbol: METAP2
3 Cross references
220 Possible Orthologues:

Microtubule-Associated Protein Tau A

Ensembl ID : ENSLCRG00005017314
Gene Symbol: MAPTA
2 Cross references
205 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSLCRG00005006870
Gene Symbol: MAPK1
3 Cross references
209 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSLCRG00005005309
Gene Symbol: MAPK10
3 Cross references
88 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSLCRG00005010317
Gene Symbol: MAPK11
3 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSLCRG00005019366
Gene Symbol: MAPK14
3 Cross references
206 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSLCRG00005004242
Gene Symbol: MAPK14
3 Cross references
224 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSLCRG00005003003
Gene Symbol: MAPK3
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).